Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4 clinical trials
Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer

PERSEUS1 is an open-label, single arm, phase II trial evaluating the efficacy of Pembrolizumab in metastatic castration resistant prostate cancer (mCRPC) patients (Part A) with a biomarker enrichment stage (Part B) if efficacy is shown in part A.

bone lesions
cabazitaxel
major surgery
gonadotropin
antiandrogen therapy
  • 0 views
  • 24 Jan, 2021
  • 1 location
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time 9 months at the time of study entry.

apalutamide
bone scan
luteinizing hormone-releasing hormone agonist
immunological adjuvant
metastasis
  • 496 views
  • 23 Jan, 2021
  • 68 locations
Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients

-releasing hormone (LHRH) analogue with the use of Whole Boby (WB) DW-MRI.

bone scan
prostate cancer metastatic
prostate carcinoma
cancer
ct scan
  • 109 views
  • 22 Jan, 2021
Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

The purpose of this study is to determine what effects (good and bad) cabozantinib has in treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). The hypothesis for this trial is that cabozantinib has anti-tumor activity in a molecularly-selected group of patients with CRPC.

  • 0 views
  • 02 Apr, 2021
  • 4 locations